Literature DB >> 21213371

Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles.

Jessie Auclair1, Thomas Vaissière, Françoise Desseigne, Christine Lasset, Valérie Bonadona, Sophie Giraud, Jean-Christophe Saurin, Marie-Odile Joly, Dominique Leroux, Laurence Faivre, Carole Audoynaud, Gilles Montmain, Eric Ruano, Zdenko Herceg, Alain Puisieux, Qing Wang.   

Abstract

Constitutional epimutation is one of the causes for MLH1 gene inactivation associated with hereditary non-polyposis colon cancer (HNPCC) syndrome. Here we investigate MLH1 promoter hypermethylation in 110 sporadic early-onset colorectal cancer patients. Variable levels of hypermethylation were detected in 55 patients (50%). Importantly a reduced MLH1 gene expression was found in patients with high-level methylation, with the association of microsatellite instability (MSI) in their tumor cells. Such high-level methylation accounts for 7.4% of all patients included in this study. Furthermore, we found that in one case constitutional methylation affected both alleles, indicating a post-zygotic methylation dysregulation. Our findings suggest that constitutional epimutation is a mechanism underlying early-onset colorectal cancer, although it is involved in only a small proportion of patients, who require appropriate surveillance. Our findings provide further insight into the role of aberrant constitutional methylation in colon carcinogenesis and raise the question of whether prevalent low-level methylation constitutes a potential risk factor for cancer development. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21213371     DOI: 10.1002/gcc.20842

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.

Authors:  Christina Michailidi; Stamatios Theocharis; Gerasimos Tsourouflis; Vasiliki Pletsa; Gregorios Kouraklis; Efstratios Patsouris; Athanasios G Papavassiliou; Constantinos Troungos
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-23

2.  MLH1 methylation screening is effective in identifying epimutation carriers.

Authors:  Marta Pineda; Pilar Mur; María Dolores Iniesta; Ester Borràs; Olga Campos; Gardenia Vargas; Sílvia Iglesias; Anna Fernández; Stephen B Gruber; Conxi Lázaro; Joan Brunet; Matilde Navarro; Ignacio Blanco; Gabriel Capellá
Journal:  Eur J Hum Genet       Date:  2012-07-04       Impact factor: 4.246

Review 3.  The role of epigenetics in Lynch syndrome.

Authors:  Megan P Hitchins
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 4.  DNA methyltransferases, DNA damage repair, and cancer.

Authors:  Bilian Jin; Keith D Robertson
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 5.  Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes.

Authors:  Qing Wang
Journal:  Acta Pharmacol Sin       Date:  2015-11-30       Impact factor: 6.150

6.  Relationship Between Human mutL Homolog 1 (hMLH1) Hypermethylation and Colorectal Cancer: A Meta-Analysis.

Authors:  Hui-Feng Zhang; You-Wang Lu; Zhen-Rong Xie; Kun-Hua Wang
Journal:  Med Sci Monit       Date:  2017-06-21

7.  Highly sensitive MLH1 methylation analysis in blood identifies a cancer patient with low-level mosaic MLH1 epimutation.

Authors:  Estela Dámaso; Júlia Canet-Hermida; Gardenia Vargas-Parra; Àngela Velasco; Fátima Marín; Esther Darder; Jesús Del Valle; Anna Fernández; Àngel Izquierdo; Gemma Mateu; Glòria Oliveras; Carmen Escribano; Virgínia Piñol; Hugo-Ikuo Uchima; José Luis Soto; Megan Hitchins; Ramon Farrés; Conxi Lázaro; Bernat Queralt; Joan Brunet; Gabriel Capellá; Marta Pineda
Journal:  Clin Epigenetics       Date:  2019-11-28       Impact factor: 6.551

8.  Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis.

Authors:  Takashi Takeda; Kouji Banno; Megumi Yanokura; Masataka Adachi; Moito Iijima; Haruko Kunitomi; Kanako Nakamura; Miho Iida; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Wataru Yamagami; Akira Hirasawa; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

9.  Identification of genetic variants for clinical management of familial colorectal tumors.

Authors:  Mev Dominguez-Valentin; Sigve Nakken; Hélène Tubeuf; Daniel Vodak; Per Olaf Ekstrøm; Anke M Nissen; Monika Morak; Elke Holinski-Feder; Alexandra Martins; Pål Møller; Eivind Hovig
Journal:  BMC Med Genet       Date:  2018-02-20       Impact factor: 2.103

10.  Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.

Authors:  Diana Pinto; Carla Pinto; Joana Guerra; Manuela Pinheiro; Rui Santos; Hege Marie Vedeld; Zeremariam Yohannes; Ana Peixoto; Catarina Santos; Pedro Pinto; Paula Lopes; Ragnhild Lothe; Guro Elisabeth Lind; Rui Henrique; Manuel R Teixeira
Journal:  Cancer Med       Date:  2018-01-17       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.